Business Description
Zhejiang Xianju Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000K64
Share Class Description:
SZSE:002332: Class ACompare
Compare
Traded in other countries / regions
002332.China IPO Date
2010-01-12Description
Zhejiang Xianju Pharmaceutical Co Ltd is a China-based company engaged in the production and sale of drugs. It mainly produces corticosteroids, sex hormones (gynecology and family planning drugs) and anesthesia and muscle relaxants.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 12.36 | |||||
| Equity-to-Asset | 0.87 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.14 | |||||
| Interest Coverage | 336.85 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 10.88 | |||||
| Beneish M-Score | -2.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.6 | |||||
| 3-Year EBITDA Growth Rate | -1.8 | |||||
| 3-Year EPS without NRI Growth Rate | 2.6 | |||||
| 3-Year FCF Growth Rate | -20.7 | |||||
| 3-Year Book Growth Rate | 9.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 22.82 | |||||
| Future 3-5Y Total Revenue Growth Rate | 11.82 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.27 | |||||
| 9-Day RSI | 42.66 | |||||
| 14-Day RSI | 44.98 | |||||
| 6-1 Month Momentum % | 9.48 | |||||
| 12-1 Month Momentum % | 11.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.34 | |||||
| Quick Ratio | 3.12 | |||||
| Cash Ratio | 1.76 | |||||
| Days Inventory | 179.2 | |||||
| Days Sales Outstanding | 56.5 | |||||
| Days Payable | 88.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.43 | |||||
| Dividend Payout Ratio | 0.46 | |||||
| 3-Year Dividend Growth Rate | 44.2 | |||||
| Forward Dividend Yield % | 2.43 | |||||
| 5-Year Yield-on-Cost % | 12.03 | |||||
| Shareholder Yield % | 3.47 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.53 | |||||
| Operating Margin % | 17.82 | |||||
| Net Margin % | 15.08 | |||||
| FCF Margin % | 1.75 | |||||
| ROE % | 10.66 | |||||
| ROA % | 8.87 | |||||
| ROIC % | 13.69 | |||||
| ROC (Joel Greenblatt) % | 23.56 | |||||
| ROCE % | 12.13 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.48 | |||||
| Forward PE Ratio | 14.44 | |||||
| PE Ratio without NRI | 18.96 | |||||
| Shiller PE Ratio | 26.63 | |||||
| Price-to-Owner-Earnings | 26.33 | |||||
| PEG Ratio | 2.92 | |||||
| PS Ratio | 2.93 | |||||
| PB Ratio | 2.01 | |||||
| Price-to-Tangible-Book | 2.31 | |||||
| Price-to-Free-Cash-Flow | 165.5 | |||||
| Price-to-Operating-Cash-Flow | 37.39 | |||||
| EV-to-EBIT | 15.12 | |||||
| EV-to-EBITDA | 15.12 | |||||
| EV-to-Revenue | 2.67 | |||||
| EV-to-FCF | 156.92 | |||||
| Price-to-Projected-FCF | 1.48 | |||||
| Price-to-DCF (Earnings Based) | 0.61 | |||||
| Price-to-DCF (FCF Based) | 5.3 | |||||
| Price-to-Median-PS-Value | 1.09 | |||||
| Price-to-Graham-Number | 1.39 | |||||
| Price-to-Net-Current-Asset-Value | 5.26 | |||||
| Price-to-Net-Cash | 29.88 | |||||
| Earnings Yield (Greenblatt) % | 6.61 | |||||
| FCF Yield % | 0.59 | |||||
| Forward Rate of Return (Yacktman) % | 5.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zhejiang Xianju Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,122.967 | ||
| EPS (TTM) (Â¥) | 0.629 | ||
| Beta | 1.15 | ||
| Volatility % | 45.79 | ||
| 14-Day RSI | 44.98 | ||
| 14-Day ATR (Â¥) | 0.416339 | ||
| 20-Day SMA (Â¥) | 12.585 | ||
| 12-1 Month Momentum % | 11.29 | ||
| 52-Week Range (Â¥) | 8.44 - 14.8 | ||
| Shares Outstanding (Mil) | 989.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zhejiang Xianju Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zhejiang Xianju Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zhejiang Xianju Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Xianju Pharmaceutical Co Ltd(SZSE:002332)'s stock price today?
The current price of SZSE:002332 is ¥12.25. The 52 week high of SZSE:002332 is ¥14.80 and 52 week low is ¥8.44.
When is next earnings date of Zhejiang Xianju Pharmaceutical Co Ltd(SZSE:002332)?
The next earnings date of Zhejiang Xianju Pharmaceutical Co Ltd(SZSE:002332) is .
Does Zhejiang Xianju Pharmaceutical Co Ltd(SZSE:002332) pay dividends? If so, how much?
The Dividend Yield %  of Zhejiang Xianju Pharmaceutical Co Ltd(SZSE:002332) is 2.43% (As of Today), Highest Dividend Payout Ratio of Zhejiang Xianju Pharmaceutical Co Ltd(SZSE:002332) was 0.56. The lowest was 0.16. And the median was 0.25. The  Forward Dividend Yield % of Zhejiang Xianju Pharmaceutical Co Ltd(SZSE:002332) is 2.43%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers